Search
  • Site Search
  • News
  • Product
  • Zhejiang Medical Technology Development Co., Ltd.

    Common name

    Naftopidil Tablets

    Product name Flivas®
    Common name

    Naftopidil Tablets

    Product manufacturer

     Asahi Kasei Pharma Corporation,Nagoya Pharmaceuticals Plant

    Product approval

    H20200016

    Indication

    It is suitable for unrination dysfunction caused by benign prostatic hyperplasia

    Specification

    (1)25 mg;(2)50 mg

    Dosage

    To be taken after meal orally.

    For adults, the initial dose of naltopil is usually 25 mg once daily. If efficacy is not satisfactory, the dose can be gradually increased to 50 mg-75 mg once daily after an interval of 1 to 2 weeks.

    In addition, the dose should be increased or decreased according to symptoms, but the maximum daily dose should not exceed 75mg.

    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358    4008393773 ( Product Hotline )
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.